Ulcer treatment trial for active eye infection
Part of Eyes & vision, Infections clinical trials.
This trial tests a new treatment for people who still have eye inflammation after 1 month of standard treatment for a parasitic eye infection (acanthamoeba keratitis). It aims to find a better way to control the infection and reduce inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of acanthamoeba keratitis (a parasitic eye infection) through tests like culture or PCR.
- You must have active eye inflammation (redness, swelling) after 1 month of anti-amoebic treatment.
- You cannot have certain other eye infections (like herpes or fungus) or a history of certain eye problems.
- You cannot have a hole in your cornea or be at risk for one.
- You cannot have had a cornea transplant for this infection.
- You cannot be using steroid medications for other conditions or have an allergy to steroids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a natural compound called resveratrol (and a nanoparticle version) as a possible treatment for Acanthamoeba eye infections, which cause painful corneal ulcers. If you have this type of infection, the treatment might help heal your eye.
This trial tests if adding cyclosporine A to the standard natamycin eye drops can better treat fungal eye infections. It may help people with moderate vision loss from a fungal corneal infection.
This trial tests a new eye drop (acoltrepon) to see if it helps people with stage 1 neurotrophic keratopathy (a condition where the cornea's nerves are damaged, causing dry eyes and vision problems) and low tear production. It aims to improve signs like corneal staining and symptoms of discomfort.
This study is testing a steroid eye drop (fluorometholone) as an add-on to standard antibiotic treatment for bacterial corneal ulcers. The goal is to see if adding the steroid helps reduce inflammation and improves healing compared to antibiotics alone.
This study tests a new light-based treatment for a fungal eye infection called Fusarium keratitis. It aims to see if this therapy can help improve vision and clear the infection.
This trial tests a new type of antibiotic eye drop for people with serious eye infections that don't respond to standard antibiotics. It aims to see if these drops can safely treat the infection and help improve vision.
Hear when a new Acanthamoeba Keratitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.